CVS Health (NYSE:CVS) Reaches New 12-Month High – Here’s What Happened

CVS Health Corporation (NYSE:CVS) shares reached a new 52-week high during trading on Monday . The stock traded as high as $103.12 and last traded at $102.8930, with a volume of 3990807 shares. The stock had previously closed at $98.32.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CVS shares. Bank of America boosted their target price on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday. Wells Fargo & Company raised their price target on CVS Health from $102.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Sanford C. Bernstein lifted their price target on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research report on Tuesday, May 12th. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, JPMorgan Chase & Co. increased their price objective on CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a report on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $101.28.

CVS Health Stock Performance

The company’s fifty day simple moving average is $90.21 and its 200 day simple moving average is $81.86. The stock has a market capitalization of $128.50 billion, a P/E ratio of 44.42, a P/E/G ratio of 0.99 and a beta of 0.62. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. During the same quarter last year, the business posted $2.25 earnings per share. The firm’s revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 7.44 earnings per share for the current fiscal year.

Insider Transactions at CVS Health

In other CVS Health news, Director Larry Robbins sold 370,462 shares of CVS Health stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the sale, the director directly owned 4,824,799 shares in the company, valued at $450,877,466.55. The trade was a 7.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. This represents a 87.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 3,441,551 shares of company stock valued at $323,703,977. Corporate insiders own 0.85% of the company’s stock.

Institutional Trading of CVS Health

A number of hedge funds have recently made changes to their positions in CVS. Sapient Capital LLC bought a new position in CVS Health in the first quarter valued at $204,000. Pacer Advisors Inc. lifted its stake in CVS Health by 1,020.7% during the first quarter. Pacer Advisors Inc. now owns 4,845,221 shares of the pharmacy operator’s stock worth $347,984,000 after purchasing an additional 4,412,882 shares during the last quarter. Pine Valley Investments Ltd Liability Co boosted its holdings in shares of CVS Health by 4.2% in the 1st quarter. Pine Valley Investments Ltd Liability Co now owns 18,820 shares of the pharmacy operator’s stock worth $1,352,000 after purchasing an additional 763 shares in the last quarter. DV Trading LLC raised its holdings in shares of CVS Health by 213.2% during the 1st quarter. DV Trading LLC now owns 3,000 shares of the pharmacy operator’s stock valued at $215,000 after buying an additional 2,042 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in CVS Health by 7.5% in the 1st quarter. Parallel Advisors LLC now owns 12,478 shares of the pharmacy operator’s stock worth $896,000 after buying an additional 869 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.